Geode Capital Management’s Artelo Biosciences ARTL Stock Holding History
Bought
Maintained
Sold
Other funds holding ARTL
AS
KCM
VCM
VFT
TRCT
CS
RIL
Geode Capital Management's ARTL Position: Q1 2026 in Review
Geode Capital Management sold out of Artelo Biosciences (ARTL) in Q1 2026, closing a stake of 3,799 shares — an estimated $13.9K sold.
Geode Capital Management first reported a position in ARTL in Q4 2020 and held it in 20 quarters. The position peaked at $230K in Q1 2021. 11 funds tracked by Wall St. Rank hold ARTL as of Q1 2026.
- Geode Capital Management reported no remaining Artelo Biosciences position as of Q1 2026 after selling out during the quarter.
- Geode Capital Management sold 3,799 Artelo Biosciences shares in Q1 2026, an estimated $13.9K.
- Geode Capital Management first reported a position in Artelo Biosciences in Q4 2020 and held it in 20 quarters.
- Geode Capital Management's Artelo Biosciences position peaked at $230K in Q1 2021.
- 11 funds tracked by Wall St. Rank held Artelo Biosciences as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.